Evidence map›Paper›PMID 41105015›Full record

ArticleGigaScience2025

Cross-modal contrastive learning decodes developmental regulatory features through chromatin potential analysis.

Yueyuxiao Yang, Chenxi Xie, Qiushun He, Meng Yang

Abstract read
In one paragraph

Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yueyuxiao YangMGI Tech Co., Ltd., Shenzhen 518083, China.ORCID 0000-0001-8312-7100
Chenxi XieMGI Tech Co., Ltd., Shenzhen 518083, China.ORCID 0000-0003-3784-6993
Qiushun HeMGI Tech Co., Ltd., Shenzhen 518083, China.ORCID 0000-0002-3805-1925
Meng YangMGI Tech Co., Ltd., Shenzhen 518083, China.ORCID 0000-0001-5630-6357

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmerging large-scale multimodal single-cell data jointly measure chromatin accessibility and transcription in the same cell, thus reconciling matched data paves an integrated route for comprehensive regulatory analysis.

findingsHere, we introduce Attune, a cross-modal contrastive learning framework to align paired gene expression and accessibility information. Systematic benchmarking shows Attune's superior performance for omics integration and gene expression prediction. We further introduce transformer-based cross-modal attention over fine-tuned gene and peak embeddings to infer regulatory interaction and discover significant differential signals of cell subtypes. Applied to a hair follicle maturation dataset, Attune reveals chromatin potential for the bifunctional transcription factor Gli3 at the gene level. In addition, the paired representations determine transmitted states across neonatal and mature cell types of cortical neuron differentiation at the cell level. Taken together, Attune offers an approach for regulatory inference across omics layers and enables more advanced omics analyses.

conclusionsAttune offers a versatile framework for integrating gene expression and chromatin accessibility, enabling the inference of regulatory mechanisms and the prediction of gene expression from cross-modal data.

Indexed as

ChromatinComputational BiologyMachine LearningTranscription, GeneticAnimalsCell DifferentiationCerebral CortexChromatin Immunoprecipitation SequencingDatasets as TopicGene Expression Regulation, DevelopmentalHair FollicleHumansMiceNerve Tissue ProteinsNeuronsSingle-Cell Gene Expression AnalysisChromatinGli3 protein, mouseNerve Tissue ProteinsZinc Finger Protein Gli3chromatin potential analysiscontrastive learningdevelopmental regulationmultimodality

Identifiers

PMID41105015
PMCPMC12532322

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.